DeepMed Research

Huazhong University Of Science And Technology Press Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: glargine + exenatide
Drug: aspart 30

First Posted Date: 2015-06-10

Last Posted Date: 2018-11-14

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 349

Registration Number: NCT02467920

Locations: 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and technology, Wuhan, Hubei, China

The Early Stockholm Obesity Prevention Project in China

Conditions: Pediatric Obesity

First Posted Date: 2015-04-07

Last Posted Date: 2018-03-05

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 300

Registration Number: NCT02409875

Locations: 🇨🇳
Tongji Medical College, Wuhan, Hubei, China

Infrahepatic Inferior Vena Cava Clamping Versus Selective Hepatic Vascular Exclusion Involving the Portal Triad Clamping

Not Applicable

Conditions: Liver Cirrhosis
Liver Neoplasms

Interventions: Procedure: Selective hepatic vascular exclusion
Procedure: Infrahepatic inferior vena cava clamping
Procedure: Portal triad clamping

First Posted Date: 2015-04-01

Last Posted Date: 2015-04-01

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 120

Registration Number: NCT02405416

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

Early Stockholm Obesity Prevention Program (EarlySTOPP-China)

Conditions: Obesity
Overweight

First Posted Date: 2015-03-24

Last Posted Date: 2018-03-05

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 300

Registration Number: NCT02396784

Locations: 🇨🇳
Tongji Medical College, Wuhan, Hubei, China

Comparison of McGrath Series 5 and Airtraq Videolaryngoscope for Double-lumen Tube (DLT) Intubation

Not Applicable

Completed

Conditions: Thoracic Disease
Intubation;Difficult
Intubation Complication

Interventions: Device: Airtraq
Device: McGrath Series 5

First Posted Date: 2014-12-31

Last Posted Date: 2017-04-04

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 90

Registration Number: NCT02329041

Locations: 🇨🇳
Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China

Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion

Not Applicable

Conditions: Lymphatic Metastasis
Unknown Primary Neoplasm Metastasis
Pancreas Neoplasms
Neoplasm Metastases

Interventions: Device: EUS-FNA (EchoTip Ultra)
Device: EUS-FNB (EchoTip ProCore)

First Posted Date: 2014-12-30

Last Posted Date: 2014-12-30

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 408

Registration Number: NCT02327065

Locations: 🇨🇳
Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer

Phase 4

Completed

Conditions: Liver Cancer
Cirrhosis

Interventions: Drug: Omega-3 Fatty Acid-Based Parenteral Nutrition
Drug: Structolipid

First Posted Date: 2014-12-22

Last Posted Date: 2018-08-22

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 320

Registration Number: NCT02321202

Locations: 🇨🇳
Hepatic Surgery Center of Tongji Hospital, Wuhan, Hubei, China

The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness

Not Applicable

Conditions: Eye Disease

Interventions: Drug: LONGEVINEX
Drug: placebo

First Posted Date: 2014-12-22

Last Posted Date: 2015-04-03

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 34

Registration Number: NCT02321189

Locations: 🇨🇳
Tongji Medical College of HUST, Wuhan, Hubei, China

Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood

Not Applicable

Conditions: Eye Disease

Interventions: Drug: trans-resveratrol

First Posted Date: 2014-12-22

Last Posted Date: 2014-12-22

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 20

Registration Number: NCT02321176

Locations: 🇨🇳
Tongji Medical College of HUST, Wuhan, Hubei, China

Rapid Ligating the Corresponding Inflow and Outflow Vessels Without Hilus Dissection During Hepatectomy

Not Applicable

Conditions: Cancer Progression

Interventions: Procedure: hepatectomy (rapid ligating)
Procedure: hepatectomy (conventional method)

First Posted Date: 2014-12-18

Last Posted Date: 2014-12-18

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 600

Registration Number: NCT02319863

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy